A Combination of Redeployed Drugs Demonstra Potent Anti-leukaemia and Anti-lymphoma Activity through Disruption of Tumour Cell de Novo LipogenesisThursday, 11 September 2014 at 15:00 Add to Calendar ▼2014-09-11 15:00:002014-09-11 16:00:00Europe/LondonA Combination of Redeployed Drugs Demonstra Potent Anti-leukaemia and Anti-lymphoma Activity through Disruption of Tumour Cell de Novo LipogenesisMetabomeeting 2014 in London, UKLondon, UKSELECTBIOenquiries@selectbiosciences.com The anti-leukemic therapy of bezafibrate and medroxyprogesterone acetate decreases lipogenesis in leukaemia and lymphoma cells. Lipogenic disruption is important for the anti-cancer activity of the treatment and is mediated by alteration of key enzymes in fatty acid synthesis. |